Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

COVID19 impact on the pension risk transfer market

This has had a compounding impact on the premium rates insurers charge for BPA policies.

The strong demand from trustees and sponsors of pension schemes to purchase BPAs during 2019 gave insurers a strong negotiating hand to choose which counterparties they would engage with. Consequently, insurers’ focus has gravitated towards larger transactions (where the prize was worth the risk of being unsuccessful). Whilst competition amongst insurers enabled larger schemes to maintain a comparatively strong negotiating position, insurers’ strong pipeline of business opportunities has caused their appetite to price aggressively to be muted.

For smaller schemes, with negotiating levers being much more limited, the only route to market was often to partner with a single provider. Under this approach, the insurer is set a price target that is required to meet for the transaction to proceed. Even where such an approach is followed, the expectations of managers and trustees of schemes looking to carry out very small transactions have had to be carefully managed: the smaller the transaction, the poorer the terms offered.

In January and February, it looked like 2020 would follow a similar narrative to 2019. Insurers continued to anticipate a strong pipeline of activity, albeit the average size of transactions was expected to fall slightly as they expected fewer £1bn+ in transactions to complete in 2020 compared to 2019.

The challenges following COVID-19

Everything changed in March as it became clear that COVID-19 had become a global pandemic and that, in addition to human suffering and deaths, there was going to be a severe downturn in the global economy. Companies across the globe are scaling back their operations and seeking, where possible, to preserve cash.

Consequently, discretionary expenditure is being deferred or cancelled. This extends to pension de-risking projects, with insurers now anticipating a curtailment to their 2020 pipeline as companies (a) are less inclined to pay cash top-ups to cover funding shortfalls against the cost of buying out a pension scheme’s liabilities, (b) consider the negative accounting impact of a BPA transaction on the company’s balance sheet as unattractive, and (c) are withholding budgetary approval in respect of the costs of transacting a BPA.

Read more @Actuarial Post